South Korea's coronary stents market driven by growing PCI use

About 600,000 of the population suffer from angina pectoris and heart attacks.

The coronary stents market in South Korea is expected to grow at a compound annual growth rate of 11.7% between 2020 and 2025, driven by a rising use of percutaneous coronary interventions for the treatment of heart diseases, a report from GlobalData revealed.

Amongst these, drug eluting stents (DES) accounted for more than 95% of the South Korean coronary market in 2020.

“With about 600,000 population suffering from angina pectoris and myocardial infarction in 2020, there is a strong demand for coronary stenting procedure in South Korea,” GlobalData’s medical devices analyst Vedant Goswami said.

In addition, the coronary stents market growth in South Korea is driven by improved outcomes of stenting procedures and lower prices. Access to quality healthcare facilities and better screening and diagnosis are expected to further boost the market growth, the report stated.

The wide use of DES devices in coronary stenting procedures in South Korea can be attributed to their superior clinical outcomes compared to other stents, Goswami said.

“This trend is expected to continue in the future mainly due to the decline of bare metal stents’ usage and long-term clinical trials assessing the safety and effectiveness of bioabsorbable stents are still under progress,” Goswami added.